Illumina Inc
(NAS:ILMN)
$
151.5
0.41 (0.27%)
Market Cap: 24.03 Bil
Enterprise Value: 25.76 Bil
PE Ratio: 0
PB Ratio: 11.26
GF Score: 80/100 Illumina Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript
Aug 12, 2020 / 05:00PM GMT
Release Date Price:
$334.51
(+0.86%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Welcome to the day 2 of the conference.
Sorry for the lack of video. There was a power outage with our supplier. Hopefully, we'll get it rectified here shortly. So unfortunately, we're going to have audio only. But certainly, I don't think it will lack any of the content that will be coming through. Really pleased to be joined by Francis deSouza, President and CEO, obviously, of Illumina. Illumina has been the key anchor tenant here since the conference was started, I don't know, 6 or 7 years ago.
So Francis, we certainly appreciate your being with us today and giving us your time.
Francis A. deSouza
Illumina, Inc. - CEO, President & Director
Thank you, Dan, for having me.
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Terrific. I think you may wanted to read the safe harbor statement before we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot